Jenny Rooke PhD, shares with Fortune how early-stage investors can best prepare for an uncertain future.
Read More
BrightSpec, Inc., a life science tools company commercializing Molecular Rotational Resonance (MRR) spectroscopy, announced today the closing of an $18.4 million Series C financing round, led by Genoa Ventures and Arboretum Ventures.
Read More
Genoa Ventures Founder and Managing Partner, Jenny Rooke, has been honored by the San Francisco Business Times as one of the Most Influential Women in Bay Area Business of 2021.
Read More
We are honored to be named to Inc Magazine’s 2021 Founder-Friendly Investors, a list of the best PE and VC firms with a track record of success backing entrepreneurs. It’s a privilege to help entrepreneurs build their vision into world-changing ideas. See the full list here.
Read More
"It's a hard way of living. It's a lot more work. There's all the science risk of a therapeutic — it may or may not work, the complexity of the biology — and all the execution slog of a real, scalable market."
Read More
Listen as our founder Jenny Rooke is interviewed by Luke Timmerman for The Long Run, a biotech podcast.
Read More